Biotech 2010 to Feature Alex Gorsky, Worldwide
Chairman, Medical Devices and Diagnostics Group
of Johnson & Johnson, as Luncheon Keynote
Keynote to address challenges and opportunities in changing healthcare environment at tenth annual
bioscience symposium on October 28, 2010
September 14, 2010 10:54 AM Eastern Daylight Time
TRENTON, N.J. & WAYNE, Pa.--(EON: Enhanced Online News)--Biotech 2010, the tenth annual joint
symposium of BioNJ and Pennsylvania Bio, will feature Alex Gorsky, worldwide chairman, Medical Devices and
Diagnostics Group of Johnson & Johnson, as the luncheon keynote speaker on Thursday, October 28th.
Biotech 2010 will be held October 27-28, 2010, at the Pennsylvania Convention Center in Philadelphia. In addition
to the luncheon keynote address by Mr. Gorsky, the symposium will also feature panel discussions, two plenary
sessions, a dinner keynote address, Partnering sessions, Company Presentations, an Innovation Corridor and an
Mr. Gorsky’s address will focus on the challenges and opportunities presented by today’s rapidly changing
healthcare environment, both in the U.S. and globally. He also will discuss the evolving relationship between large
and small companies and how they can work together to better serve patients.
Alex Gorsky assumed his role as the worldwide chairman of the Medical Devices and Diagnostics Group in
September 2009. He began his Johnson & Johnson career as a sales representative with Janssen Pharmaceutica in
1988. Over the next 15 years, he advanced through positions of increasing responsibility in sales, marketing, and
management and, in 2001, was appointed president of Janssen. In 2003, he was promoted to company group
chairman of Johnson & Johnson’s pharmaceutical business in Europe, the Middle East, and Africa. He left Johnson
& Johnson in 2004 to serve as the COO for Novartis Pharmaceuticals Corporation. In 2005, he was named head of
Pharma North America and CEO for Novartis.
Mr. Gorsky returned to Johnson & John